These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11901303)

  • 1. Clostridium spores for tumor-specific drug delivery.
    Nuyts S; Van Mellaert L; Theys J; Landuyt W; Lambin P; Anné J
    Anticancer Drugs; 2002 Feb; 13(2):115-25. PubMed ID: 11901303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters.
    Nuyts S; Theys J; Landuyt W; van Mellaert L; Lambin P; Anné J
    Anticancer Res; 2001; 21(2A):857-61. PubMed ID: 11396175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific gene delivery using genetically engineered bacteria.
    Theys J; Barbé S; Landuyt W; Nuyts S; Van Mellaert L; Wouters B; Anné J; Lambin P
    Curr Gene Ther; 2003 Jun; 3(3):207-21. PubMed ID: 12762480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium as a tumor-specific delivery system of therapeutic proteins.
    Theys J; Landuyt AW; Nuyts S; Van Mellaert L; Lambin P; Anné J
    Cancer Detect Prev; 2001; 25(6):548-57. PubMed ID: 12132875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.
    Theys J; Landuyt W; Nuyts S; Van Mellaert L; van Oosterom A; Lambin P; Anné J
    Cancer Gene Ther; 2001 Apr; 8(4):294-7. PubMed ID: 11393282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.
    Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM
    Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of clostridial spores for cancer treatment.
    Barbé S; Van Mellaert L; Anné J
    J Appl Microbiol; 2006 Sep; 101(3):571-8. PubMed ID: 16907807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridia in cancer therapy.
    Minton NP
    Nat Rev Microbiol; 2003 Dec; 1(3):237-42. PubMed ID: 15035028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis.
    Liu SC; Minton NP; Giaccia AJ; Brown JM
    Gene Ther; 2002 Feb; 9(4):291-6. PubMed ID: 11896468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy.
    Kubiak AM; Minton NP
    Res Microbiol; 2015 May; 166(4):244-54. PubMed ID: 25576776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteria and bacterial toxins as therapeutic agents for solid tumors.
    Michl P; Gress TM
    Curr Cancer Drug Targets; 2004 Dec; 4(8):689-702. PubMed ID: 15578923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation.
    Nuyts S; Van Mellaert L; Theys J; Landuyt W; Bosmans E; Anné J; Lambin P
    Gene Ther; 2001 Aug; 8(15):1197-201. PubMed ID: 11509951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridial spores to treat solid tumours - potential for a new therapeutic modality.
    Mengesha A; Wei JZ; Zhou SF; Wei MQ
    Curr Gene Ther; 2010 Feb; 10(1):15-26. PubMed ID: 20158471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic tumour targeting using clostridial spores.
    Minton NP; Mauchline ML; Lemmon MJ; Brehm JK; Fox M; Michael NP; Giaccia A; Brown JM
    FEMS Microbiol Rev; 1995 Oct; 17(3):357-64. PubMed ID: 7576773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer.
    Nuyts S; Van Mellaert L; Theys J; Landuyt W; Lambin P; Anné J
    Radiat Res; 2001 May; 155(5):716-23. PubMed ID: 11302769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-based transcriptional analysis of Clostridium sporogenes UC9000 during germination, cell outgrowth and vegetative life.
    Bassi D; Cappa F; Cocconcelli PS
    Food Microbiol; 2013 Feb; 33(1):11-23. PubMed ID: 23122496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
    Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM
    Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium-mediated transfer system of therapeutic proteins to solid tumors: increased heterologous protein production.
    Barbé S; Van Mellaert L; Anné J
    Commun Agric Appl Biol Sci; 2004; 69(2):49-52. PubMed ID: 15560185
    [No Abstract]   [Full Text] [Related]  

  • 19. A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer.
    Li Z; Fallon J; Mandeli J; Wetmur J; Woo SL
    J Natl Cancer Inst; 2008 Oct; 100(19):1389-400. PubMed ID: 18812551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoxia in malignant tumors the target for clostridial therapeutic gene strategies].
    Wallner G; Misiuna P; Cygan W; Cygan Z
    Pol Merkur Lekarski; 2005 Aug; 19(110):242-4. PubMed ID: 16245444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.